APA (7th ed.) Citation

Black, C. J., & Ford, A. C. (2021). Editorial: Co‐morbid gastrointestinal conditions are an important consideration in IBS management—authors' reply. Alimentary Pharmacology & Therapeutics, 53(10), 1153. https://doi.org/10.1111/apt.16351

Chicago Style (17th ed.) Citation

Black, Christopher J., and Alexander C. Ford. "Editorial: Co‐morbid Gastrointestinal Conditions Are an Important Consideration in IBS Management—authors' Reply." Alimentary Pharmacology & Therapeutics 53, no. 10 (2021): 1153. https://doi.org/10.1111/apt.16351.

MLA (9th ed.) Citation

Black, Christopher J., and Alexander C. Ford. "Editorial: Co‐morbid Gastrointestinal Conditions Are an Important Consideration in IBS Management—authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 53, no. 10, 2021, p. 1153, https://doi.org/10.1111/apt.16351.